Enhanced expansion and tumor targeting of adoptively transferred T cells with NKTR-214

被引：0
|
作者：
Parisi, Giulia [1 ]
Saco, Justin [1 ]
Bergara, Felix [1 ]
Krystofinski, Paige [1 ]
Zhang, Ruixue [1 ]
Saus, Cristina Puig [1 ]
Hu-Lieskovan, Siwen [1 ]
Comin-Anduix, Begonya [1 ]
Wu, Anna [1 ]
Charych, Deborah H. [2 ]
Ribas, Antoni [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Nektar Therapeut, San Francisco, CA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3566
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comprehensive antitumor immune activation by a novel TLR7/8 targeting agent NKTR-262 combined with CD122-biased immunostimulatory cytokine NKTR-214
    Kivimae, Saul
    Hennessy, Marlene
    Pena, Rhoneil
    Kirksey, Yolanda
    Nieves, Wildaliz
    Quatch, Phi
    Cetz, Janet
    Ren, Zhongxu
    Cai, Haiying
    Deng, BoLiang
    Zhang, Wen
    Langowski, John L.
    Fanton, Christie
    Anand, Neel K.
    Rubas, Werner
    Doberstein, Steve
    Zalevsky, Jonathan
    CANCER RESEARCH, 2018, 78 (13)
  • [32] An engineered immunotherapy (NKTR-214) with altered selectivity toward the IL2 receptor: Efficacy and tolerability in a murine tumor model.
    Charych, Deborah H.
    Addepalli, Murali
    Lee, Steve
    Chang, Thomas
    Liu, Xiaofeng
    Pena, Rhoneil
    Sweeney, Terry
    Hoch, Ute
    Doberstein, Stephen K.
    Kantak, Seema S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells
    Liu, Zuqiang
    Noh, Hae S.
    Chen, Janet
    Kim, Jin H.
    Falo, Louis D.
    You, Zhaoyang
    JOURNAL OF IMMUNOLOGY, 2008, 181 (06): : 4363 - 4370
  • [34] PIVOT-02: Phase 1/2 Study of NKTR-214 and Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumor Malignancies
    Papadimitrakopoulou, V.
    Tannir, N.
    Bernatchez, C.
    Haymaker, C.
    Bentebibel, S.
    Curti, B.
    Wong, M.
    Gergel, I.
    Tagliaferri, M.
    Zalevsky, J.
    Hoch, U.
    Aung, S.
    Imperiale, M.
    Cho, D.
    Tykodi, S.
    Puzanov, I.
    Kluger, H.
    Hurwitz, M.
    Hwu, P.
    Sznol, M.
    Diab, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2152 - S2152
  • [35] Dissection of GvHD and tumor rejection by selective blockade of gut-migration of adoptively transferred T cells
    Heimann, A.
    Herda, S.
    Althoff, S.
    Russ, J.
    Blankenstein, T.
    Na, I. -K.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 162 - 163
  • [36] Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment
    Fuechsl, Franziska
    Krackhardt, Angela M.
    CANCERS, 2022, 14 (17)
  • [37] Distribution of adoptively transferred tumor-specific T cells following either intravenous or intraperitoneal injection
    Fleischer, CC
    Petersen, MS
    Hokland, M
    Agger, R
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S1 - S2
  • [38] Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor-specific CD8+ T cells
    Imai, Naoko
    Ikeda, Hiroaki
    Tawara, Isao
    Shiku, Hiroshi
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (01) : 241 - 253
  • [39] Effect of NKTR-214 on the number and activity of CD8+tumor infiltrating lymphocytes in patients with advanced renal cell carcinoma.
    Hurwitz, Michael E.
    Diab, Adi
    Bernatchez, Chantale
    Haymaker, Cara L.
    Kluger, Harriet M.
    Tetzlaff, Michael T.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [40] The fate of adoptively transferred antigen-specific T cells in vivo
    Li, Z
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (09) : 2208 - 2214
12345